Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ImmunoPrecise Antibodies ...

    NASDAQ: IPA · Real-Time Price · USD
    0.85
    0.15 (21.17%)
    At close: Jun 16, 2025, 3:59 PM
    0.83
    -2.34%
    Pre-market: Jun 17, 2025, 08:32 AM EDT

    ImmunoPrecise Antibodies Statistics

    Share Statistics

    ImmunoPrecise Antibodies has 45.77M shares outstanding. The number of shares has increased by 73.91% in one year.

    Shares Outstanding

    n/a
    		 45.77M

    Shares Change (YoY)

    n/a
    		 73.91%

    Shares Change (QoQ)

    n/a
    		 47.33%

    Owned by Institutions (%)

    n/a
    		 6.78%

    Shares Floating

    n/a
    		 39.68M

    Failed to Deliver (FTD) Shares

    n/a
    		 13,420

    FTD / Avg. Volume

    n/a
    		 0.82%

    Short Selling Information

    The latest short interest is 247.81K, so 0.54% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 247.81K

    Short % of Shares Out

    n/a
    		 0.54%

    Short % of Float

    n/a
    		 0.55%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -1.66 and the forward PE ratio is -6.38. ImmunoPrecise Antibodies's PEG ratio is 1.78.

    PE Ratio

    n/a
    		 -1.66

    Forward PE

    n/a
    		 -6.38

    PS Ratio

    n/a
    		 1.84

    Forward PS

    n/a
    		 0.8

    PB Ratio

    n/a
    		 1.33

    P/FCF Ratio

    n/a
    		 -8.01

    PEG Ratio

    n/a
    		 1.78
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for ImmunoPrecise Antibodies.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.4.

    Current Ratio

    n/a
    		 1.41

    Quick Ratio

    n/a
    		 1.15

    Debt / Equity

    n/a
    		 0.4

    Debt / EBITDA

    n/a
    		 -0.6

    Debt / FCF

    n/a
    		 -2.42

    Interest Coverage

    n/a
    		 -724.32

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $340,527.78

    Profits Per Employee

    n/a
    		 $-377,458.33

    Employee Count

    n/a
    		 72

    Asset Turnover

    n/a
    		 0.41

    Inventory Turnover

    n/a
    		 5.83

    Taxes

    Income Tax

    n/a
    		 -1.53M

    Effective Tax Rate

    n/a
    		 5.32%

    Stock Price Statistics

    The stock price has increased by -19.05% in the last 52 weeks. The beta is 0.22, so ImmunoPrecise Antibodies's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.22

    52-Week Price Change

    n/a
    		 -19.05%

    50-Day Moving Average

    n/a
    		 0.51

    200-Day Moving Average

    n/a
    		 0.49

    Relative Strength Index (RSI)

    n/a
    		 75

    Average Volume (20 Days)

    n/a
    		 1,639,785

    Income Statement

    In the last 12 months, ImmunoPrecise Antibodies had revenue of 24.52M and earned -27.18M in profits. Earnings per share was -1.06.

    Revenue

    n/a
    		 24.52M

    Gross Profit

    n/a
    		 12.05M

    Operating Income

    n/a
    		 -13.76M

    Net Income

    n/a
    		 -27.18M

    EBITDA

    n/a
    		 -22.95M

    EBIT

    n/a
    		 -28.68M

    Earnings Per Share (EPS)

    n/a
    		 -1.06
    Full Income Statement

    Balance Sheet

    The company has 3.46M in cash and 13.68M in debt, giving a net cash position of -10.22M.

    Cash & Cash Equivalents

    n/a
    		 3.46M

    Total Debt

    n/a
    		 13.68M

    Net Cash

    n/a
    		 -10.22M

    Retained Earnings

    n/a
    		 -100.27M

    Total Assets

    n/a
    		 45.53M

    Working Capital

    n/a
    		 11.81M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -4.25M and capital expenditures -1.4M, giving a free cash flow of -5.64M.

    Operating Cash Flow

    n/a
    		 -4.25M

    Capital Expenditures

    n/a
    		 -1.4M

    Free Cash Flow

    n/a
    		 -5.64M

    FCF Per Share

    n/a
    		 -0.22
    Full Cash Flow Statement

    Margins

    Gross margin is 49.16%, with operating and profit margins of -56.13% and -110.85%.

    Gross Margin

    n/a
    		 49.16%

    Operating Margin

    n/a
    		 -56.13%

    Pretax Margin

    n/a
    		 -117.07%

    Profit Margin

    n/a
    		 -110.85%

    EBITDA Margin

    n/a
    		 -93.6%

    EBIT Margin

    n/a
    		 -56.13%

    FCF Margin

    n/a
    		 -23.02%

    Dividends & Yields

    IPA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for IPA is $4, which is 370.6% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $4

    Price Target Difference

    n/a
    		 370.6%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Nov 23, 2020. It was a backward split with a ratio of 1:5.

    Last Split Date

    n/a
    		 Nov 23, 2020

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:5

    Scores

    Altman Z-Score

    n/a
    		 -4.91

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist